Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combined modality treatment for primary tumor.

H Bartelink1

  • 1Department of Radiotherapy, The Netherlands Cancer Institute, Antoni van Leeuwenhoekhuis, Amsterdam.

NCI Monographs : a Publication of the National Cancer Institute
|January 1, 1988
PubMed
Summary

Combining radiotherapy and chemotherapy shows promise but often fails due to poor drug uptake. Future research must focus on improving drug targeting and predictive assays for better cancer treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period.

Breast cancer research and treatment·2016
Same author

Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.

Breast cancer research and treatment·2014
Same author

Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancer.

European journal of cancer (Oxford, England : 1990)·2012
Same author

Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrence.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2010
Same author

The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model.

Breast cancer research and treatment·2009

Area of Science:

  • Oncology
  • Radiotherapy
  • Pharmacology

Background:

  • Combined radiotherapy and chemotherapy aim to enhance cancer treatment by utilizing cytostatic drugs.
  • While successful in some cases, this combined approach frequently fails in clinical trials.
  • Limited tumor drug uptake is a significant factor contributing to treatment failure.

Purpose of the Study:

  • To explore strategies for improving the efficacy of combined radiotherapy and chemotherapy.
  • To emphasize the need for enhanced drug targeting and predictive assays in cancer treatment.
  • To highlight the importance of pharmacokinetic studies and in vivo experiments for combined treatment evaluation.

Main Methods:

  • Investigating methods to improve drug delivery and targeting within tumors.
  • Utilizing predictive assays to identify patient response to combined therapies.
  • Conducting pharmacokinetic studies, including intracellular drug uptake measurement (e.g., cisplatin DNA adducts via immunocytochemistry).
  • Performing experimental animal studies to assess fractionated irradiation with drugs on tumors and normal tissues.

Main Results:

  • Cisplatin's intracellular uptake and DNA adduct formation can now be quantified using immunocytochemistry.
  • Experimental models allow for the evaluation of combined treatment effects on both cancerous and healthy tissues.
  • Fractionated irradiation combined with drugs requires thorough testing on early- and late-responding normal tissues.

Conclusions:

  • Improving drug targeting and employing predictive assays are crucial for advancing combined radiotherapy and chemotherapy.
  • Pharmacokinetic studies, particularly intracellular drug uptake measurements, are essential for optimizing treatment strategies.
  • Comprehensive preclinical evaluation in animal models is necessary to ensure the safety and efficacy of combined cancer therapies.

Related Experiment Videos